Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease affecting 1:5000 newborn males. No cure is currently available, but gene addition therapy, based on the adeno-associated viral (AAV) vector-mediated delivery of microdystrophin transgenes, is currently being tested in clinical trials....

Full description

Bibliographic Details
Main Authors: Viktorija Cernisova, Ngoc Lu-Nguyen, Jessica Trundle, Shan Herath, Alberto Malerba, Linda Popplewell
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/9/8174
_version_ 1797602447140585472
author Viktorija Cernisova
Ngoc Lu-Nguyen
Jessica Trundle
Shan Herath
Alberto Malerba
Linda Popplewell
author_facet Viktorija Cernisova
Ngoc Lu-Nguyen
Jessica Trundle
Shan Herath
Alberto Malerba
Linda Popplewell
author_sort Viktorija Cernisova
collection DOAJ
description Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease affecting 1:5000 newborn males. No cure is currently available, but gene addition therapy, based on the adeno-associated viral (AAV) vector-mediated delivery of microdystrophin transgenes, is currently being tested in clinical trials. The muscles of DMD boys present significant fibrotic and adipogenic tissue deposition at the time the treatment starts. The presence of fibrosis not only worsens the disease pathology, but also diminishes the efficacy of gene therapy treatments. To gain an understanding of the efficacy of AAV-based microdystrophin gene addition in a relevant, fibrotic animal model of DMD, we conducted a systemic study in juvenile <i>D2.mdx</i> mice using the single intravenous administration of an AAV8 system expressing a sequence-optimized murine microdystrophin, named MD1 (AAV8-MD1). We mainly focused our study on the diaphragm, a respiratory muscle that is crucial for DMD pathology and that has never been analyzed after treatment with AAV-microdystrophin in this mouse model. We provide strong evidence here that the delivery of AAV8-MD1 provides significant improvement in body-wide muscle function. This is associated with the protection of the hindlimb muscle from contraction-induced damage and the prevention of fibrosis deposition in the diaphragm muscle. Our work corroborates the observation that the administration of gene therapy in DMD is beneficial in preventing muscle fibrosis.
first_indexed 2024-03-11T04:16:13Z
format Article
id doaj.art-72b7832e602d4d8d822ed9b6eec6cd5d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T04:16:13Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-72b7832e602d4d8d822ed9b6eec6cd5d2023-11-17T23:05:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-01249817410.3390/ijms24098174Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular DystrophyViktorija Cernisova0Ngoc Lu-Nguyen1Jessica Trundle2Shan Herath3Alberto Malerba4Linda Popplewell5Department of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham, Surrey TW20 0EX, UKDepartment of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham, Surrey TW20 0EX, UKDepartment of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham, Surrey TW20 0EX, UKDepartment of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham, Surrey TW20 0EX, UKDepartment of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham, Surrey TW20 0EX, UKDepartment of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham, Surrey TW20 0EX, UKDuchenne muscular dystrophy (DMD) is a rare neuromuscular disease affecting 1:5000 newborn males. No cure is currently available, but gene addition therapy, based on the adeno-associated viral (AAV) vector-mediated delivery of microdystrophin transgenes, is currently being tested in clinical trials. The muscles of DMD boys present significant fibrotic and adipogenic tissue deposition at the time the treatment starts. The presence of fibrosis not only worsens the disease pathology, but also diminishes the efficacy of gene therapy treatments. To gain an understanding of the efficacy of AAV-based microdystrophin gene addition in a relevant, fibrotic animal model of DMD, we conducted a systemic study in juvenile <i>D2.mdx</i> mice using the single intravenous administration of an AAV8 system expressing a sequence-optimized murine microdystrophin, named MD1 (AAV8-MD1). We mainly focused our study on the diaphragm, a respiratory muscle that is crucial for DMD pathology and that has never been analyzed after treatment with AAV-microdystrophin in this mouse model. We provide strong evidence here that the delivery of AAV8-MD1 provides significant improvement in body-wide muscle function. This is associated with the protection of the hindlimb muscle from contraction-induced damage and the prevention of fibrosis deposition in the diaphragm muscle. Our work corroborates the observation that the administration of gene therapy in DMD is beneficial in preventing muscle fibrosis.https://www.mdpi.com/1422-0067/24/9/8174Duchenne muscular dystrophymuscle pathologyAAV8-microdystrophinfibrosis
spellingShingle Viktorija Cernisova
Ngoc Lu-Nguyen
Jessica Trundle
Shan Herath
Alberto Malerba
Linda Popplewell
Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy
International Journal of Molecular Sciences
Duchenne muscular dystrophy
muscle pathology
AAV8-microdystrophin
fibrosis
title Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy
title_full Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy
title_fullStr Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy
title_full_unstemmed Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy
title_short Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy
title_sort microdystrophin gene addition significantly improves muscle functionality and diaphragm muscle histopathology in a fibrotic mouse model of duchenne muscular dystrophy
topic Duchenne muscular dystrophy
muscle pathology
AAV8-microdystrophin
fibrosis
url https://www.mdpi.com/1422-0067/24/9/8174
work_keys_str_mv AT viktorijacernisova microdystrophingeneadditionsignificantlyimprovesmusclefunctionalityanddiaphragmmusclehistopathologyinafibroticmousemodelofduchennemusculardystrophy
AT ngoclunguyen microdystrophingeneadditionsignificantlyimprovesmusclefunctionalityanddiaphragmmusclehistopathologyinafibroticmousemodelofduchennemusculardystrophy
AT jessicatrundle microdystrophingeneadditionsignificantlyimprovesmusclefunctionalityanddiaphragmmusclehistopathologyinafibroticmousemodelofduchennemusculardystrophy
AT shanherath microdystrophingeneadditionsignificantlyimprovesmusclefunctionalityanddiaphragmmusclehistopathologyinafibroticmousemodelofduchennemusculardystrophy
AT albertomalerba microdystrophingeneadditionsignificantlyimprovesmusclefunctionalityanddiaphragmmusclehistopathologyinafibroticmousemodelofduchennemusculardystrophy
AT lindapopplewell microdystrophingeneadditionsignificantlyimprovesmusclefunctionalityanddiaphragmmusclehistopathologyinafibroticmousemodelofduchennemusculardystrophy